Head-to-head · WeighScore
HealthSource vs Henry Meds
The verdict
Henry Meds takes it — 77.3/100 to 71.2/100.
Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | HealthSource | Henry Meds |
|---|---|---|
| WeighScore | 71.2/100 | 77.3/100 |
| Grade | C | C+ |
| Scorecard rank | #105 | #48 |
| Semaglutide | $199/mo (all doses, compounded) | $197/mo (injectable; 12-month plan paid upfront in full, $2,364) |
| Tirzepatide | $299/mo (all doses, compounded) | $234/mo (compounded oral tablets; 12-month plan paid upfront in full, $2,808) |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #105 · C
Strengths
- Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
- 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
- Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
- Subscription auto-refund if monthly reassessment is not completed
- Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping
Where it loses points
- No physician names or clinical leadership disclosed on public pages
- No LegitScript certification found
- 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
- Labs not mentioned on any product page — baseline bloodwork protocol unknown
- WooCommerce e-commerce storefront may feel more transactional than clinical
Graded #48 · C+
Strengths
- Published plan prices identify their upfront-payment requirement
- Medication, provider access, applicable supplies and shipping included if prescribed
- Compounded injectable semaglutide and oral options listed
Where it loses points
- The $197 semaglutide headline requires $2,364 upfront, not monthly payments
- The listed $234 tirzepatide offer is oral compounded medication, not an injectable quote
- Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
Also worth a look
Another provider to compare: CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.